Cargando…

Predictors of Insulin Resistance in Children versus Adolescents with Obesity

INTRODUCTION: Obesity is a risk factor to develop metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). Insulin resistance (IR) plays a major part in both. With increasing incidence of childhood obesity, this retrospective study aimed to identify predictors of IR in children/adolescents wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lentferink, Yvette E., Elst, Marieke A. J., Knibbe, Catherijne A. J., van der Vorst, Marja M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742469/ https://www.ncbi.nlm.nih.gov/pubmed/29375912 http://dx.doi.org/10.1155/2017/3793868

Ejemplares similares

Increased Arterial Stiffness in Adolescents With Obesity
por: Lentferink, Yvette E., et al.
Publicado: (2019)

Asthma medication in children who are overweight/obese: justified treatment?
por: Lentferink, Yvette E., et al.
Publicado: (2019)

METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents – study protocol of a randomized controlled study
por: van der Aa, Marloes P, et al.
Publicado: (2014)

A Follow-up Study on BMI-SDS and Insulin Resistance in Overweight and Obese Children at Risk for Type 2 Diabetes Mellitus
por: Fazeli Farsani, Soulmaz, et al.
Publicado: (2015)

Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study
por: Lentferink, Y. E., et al.
Publicado: (2018)

Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial
por: van der Aa, M P, et al.
Publicado: (2016)

The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial
por: van der Aa, Marloes P., et al.
Publicado: (2016)

Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial
por: van Rongen, Anne, et al.
Publicado: (2018)

Population-Based Studies on the Epidemiology of Insulin Resistance in Children
por: van der Aa, M. P., et al.
Publicado: (2015)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

Disease History and Medication Use as Risk Factors for the Clinical Manifestation of Type 1 Diabetes in Children and Young Adults: An Explorative Case Control Study
por: Fazeli Farsani, Soulmaz, et al.
Publicado: (2014)

Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years
por: Smit, Cornelis, et al.
Publicado: (2021)

Evaluation of propofol anesthesia in morbidly obese children and adolescents
por: Chidambaran, Vidya, et al.
Publicado: (2013)

Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
por: de Wildt, Saskia N., et al.
Publicado: (2009)

Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults
por: van Rongen, Anne, et al.
Publicado: (2017)

Children Are Not Small Adults, but Can We Treat Them As Such?
por: Krekels, Elke H.J., et al.
Publicado: (2019)

Metabolic Profiles in Obese Children and Adolescents with Insulin Resistance
por: Kostovski, Marko, et al.
Publicado: (2018)

Acanthosis Nigricans as a Clinical Predictor of Insulin Resistance in Obese Children
por: Koh, Young Kwon, et al.
Publicado: (2016)

The role of uric acid in the insulin resistance in children and adolescents with obesity
por: de Miranda, Josiane Aparecida, et al.
Publicado: (2015)

Metabolic syndrome and insulin resistance in obese adolescents
por: Gobato, Amanda Oliva, et al.
Publicado: (2014)

Implications for IV posaconazole dosing in the era of obesity
por: Wasmann, Roeland E, et al.
Publicado: (2020)

Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents
por: Asghari, Golaleh, et al.
Publicado: (2018)

Prevalence of insulin resistance in obese adolescence
por: Puspitadewi, Ardita, et al.
Publicado: (2013)

Obesity-Induced Insulin Resistance Is Mediated by High Uric Acid in Obese Children and Adolescents
por: Niu, Yang, et al.
Publicado: (2021)

Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance
por: Yuan, Xin, et al.
Publicado: (2021)

Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
por: Smit, Cornelis, et al.
Publicado: (2020)

Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study
por: Smit, Cornelis, et al.
Publicado: (2019)

Obesity and insulin resistance are significant predictors of serum leptin levels
por: Beyazıt, Fatma, et al.
Publicado: (2017)

The Association of Cysteine with Obesity, Inflammatory Cytokines and Insulin Resistance in Hispanic Children and Adolescents
por: Elshorbagy, Amany K., et al.
Publicado: (2012)

Prevalence of impaired glucose tolerance and insulin resistance among obese children and adolescents
por: Ghergherechi, Robabeh, et al.
Publicado: (2010)

Effect of folic acid on homocysteine and insulin resistance of overweight and obese children and adolescents
por: Dehkordi, Elham Hashemi, et al.
Publicado: (2016)

Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function
por: Smit, Cornelis, et al.
Publicado: (2020)

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study
por: van Rhee, Koen P., et al.
Publicado: (2022)

The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties
por: Cristea, Sinziana, et al.
Publicado: (2020)

Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children
por: Goulooze, Sebastiaan C., et al.
Publicado: (2021)

An Integrated Population Pharmacokinetic Meta-Analysis of Propofol in Morbidly Obese and Nonobese Adults, Adolescents, and Children
por: Diepstraten, J, et al.
Publicado: (2013)

Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method
por: Calvier, E. A. M., et al.
Publicado: (2019)

Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents
por: Juárez-López, Carlos, et al.
Publicado: (2010)

Vitamin D Deficiency and Insufficiency in Obese Children and Adolescents and Its Relationship with Insulin Resistance
por: Torun, Emel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_27ln64khqc281n6kj580i5po4l